Can systemic inflammation cause a low T3 pattern by reducing peripheral T4→T3 conversion?

Systemic inflammation is a primary driver of altered thyroid hormone metabolism, leading to a clinical presentation frequently referred to as Non-Thyroidal Illness Syndrome (NTIS) or "low T3 syndrome." This condition is characterized by a significant drop in serum triiodothyronine (T3) levels in the absence of primary thyroid disease, reflecting an adaptive or maladaptive shift in systemic metabolic priority during illness.

Mechanisms of Deiodinase Inhibition

The reduction of peripheral T3 is primarily mediated by the suppression of deiodinase enzymes, which facilitate the conversion of thyroxine (T4) into the more biologically active T3.

• Cytokine-Induced Suppression: Pro-inflammatory cytokines, particularly interleukin-6 (IL-6), are central to this process. IL-6 directly inhibits the activity of type 1 (D1) and type 2 (D2) deiodinases.
• Oxidative Stress: IL-6 induces the intracellular depletion of glutathione (GSH). Because deiodinases are redox-dependent enzymes, this oxidative environment impairs their ability to convert T4 to T3, even if enzyme mRNA levels remain stable.
• Enzymatic Inactivation: Systemic inflammation can simultaneously upregulate type 3 deiodinase (D3). Unlike D1 and D2, D3 actively inactivates thyroid hormones, converting T4 into reverse T3 (rT3) and T3 into T2, further depleting the pool of active hormone.

Clinical and Physiological Impact

The low T3 pattern is highly prevalent in states of systemic stress, appearing in approximately 60% to 75% of intensive care patients, particularly those with sepsis or acute respiratory distress syndrome (ARDS).

• Tissue-Specific Responses: While the liver typically shows decreased D1 activity—a major source of circulating T3—some tissues like muscle may briefly increase D2 activity as a localized compensatory mechanism. However, the net systemic effect remains a significant reduction in bioavailable T3.
• Prognostic Value: Lower serum T3 levels during inflammatory states are consistently associated with poorer clinical outcomes and higher mortality rates. While often viewed as a mechanism to conserve energy during critical illness, the severity of the T3 drop serves as a robust marker of the inflammatory burden.

Bottom line

Systemic inflammation reduces peripheral T4 to T3 conversion by inhibiting D1/D2 enzyme activity and increasing D3-mediated inactivation. This biochemical shift, largely driven by IL-6, directly contributes to the low T3 pattern observed in both acute and chronic inflammatory states.